NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.85 -0.07 (-2.40%)
At close: Oct 1, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Gross Profit (2025 - 2026)

Updated

NRX Pharmaceuticals (NRXP) recorded Gross Profit of $426,000 in Q2 2026, down 9.2% from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Gross Profit (2025 - 2026) Analysis & Trends

On a TTM basis, NRX Pharmaceuticals' Gross Profit came in at $1.62 million as of Jun 30, 2026; for FY2025, it was $720,000.

  • Quarterly Gross Profit has ranged from $145,000 in Q3 2025 to $575,000 in Q4 2025 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $469,000 (Q1 2026), $575,000 (Q4 2025) and $145,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 426,000.00
Mar 31, 2026 469,000.00
Dec 31, 2025 575,000.00
Sep 30, 2025 145,000.00
API Access

NRX Pharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=NRXP&period=max&api_key=YOUR_API_KEY